Objective—To determine the effects of topically applied 2% delta-9-tetrahydrocannabinol (THC) ophthalmic solution on aqueous humor flow rate (AHFR) and intraocular...
Cannabidiol (CBD), the major non-psychoactive compound found in cannabis, is frequently used both as a nutraceutical and therapeutic. Despite anecdotal...
Vascular endothelial growth factor (VEGF) is a key regulator in both physiologic and pathologic angiogenesis, and cannabinoids decrease VEGF release...
Background: Cannabis for cancer is very topical and, given the use of illicit cannabis preparations used in this vulnerable population,...
Background Canine urothelial carcinoma is the most common form of canine bladder cancer. Treatment with chemotherapy has variable response rates...
Social media and academic literature suggest that more people are using cannabis to treat their own or their dog’s chronic...
Due to the potential risk for cannabidiol (CBD) to negatively impact the immune system, the objective of the current study...
The use of cannabis-based products for therapeutic purposes is a reality in the field of animal health. However, although cannabis...
Background & Aims: Transient lower esophageal sphincter relaxations (TLESRs) are the major cause of gastroesophageal acid reflux, and are triggered...
Objective: We aimed to examine the effects of cannabidiol (CBD)-containing hemp oil without delta-9-tetrahydrocannabinol (THC) as a supplemental treatment for...
© 2023 · Veterinary Cannabis Society